Citi Pharma Limited (KASE: CPHL)
Health Care · Pharmaceuticals · PK
PKRs64.76
-9.88% today · -27.0% 1Y
Citi Pharma Limited (KASE: CPHL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $53.43M.
Over the last twelve months the share price has lost 27.0%, trading between 63.56 and 95.50.
Tweenvest scores Citi Pharma Limited across four factors: quality 66/100, value 56/100, growth 60/100. Its strongest factor is quality.
CPHL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $53.43M
- Revenue (TTM)
- $50.63M
- P/E
- 18.72
- EPS
- 3.46
- Dividend yield
- —
- Beta (5Y)
- 0.39
- 52-week high
- PKRs95.50
- 52-week low
- PKRs63.56
- Avg volume (3M)
- —
- Shares outstanding
- 228.46M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| LeonaBio, Inc.NasdaqCM: LONA | $54.17M | $6.11 | +6.26% |
| CTCBIO Inc.KOSDAQ: A060590 | $54.06M | ₩3,040.00 | -1.62% |
| Wai Yuen Tong Medicine Holdings LimitedSEHK: 897 | $53.96M | HK$0.38 | +1.33% |
| Navana Pharmaceuticals PLCDSE: NAVANAPHAR | $53.46M | Tk61.30 | -3.46% |
| Moberg Pharma AB (publ)OM: MOB | $53.32M | Skr11.50 | +1.77% |
| Odonate, Inc.OTCPK: ODTC | $53.25M | $— | — |
| Modern Chinese Medicine Group Co., Ltd.SEHK: 1643 | $53.21M | HK$0.58 | -12.78% |
| Ildong Holdings Co., Ltd.KOSE: A000230 | $52.88M | ₩6,160.00 | -0.48% |
Figures last refreshed Oct 11, 2026.